Universal Sequencing Technology Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Universal Sequencing Technology is a biotechnology research company focused on long-read DNA sequencing solutions. Its Tell-Seq technology enables a second-generation DNA sequencer to function as a long-read sequencer, and the Tell-Seq whole-genome sequencing library prep kit is used for metagenomics, de novo assembly, whole-genome phasing, and structural variant identification. The company provides the kit and an analysis pipeline, with customers needing only samples and common lab equipment, avoiding the need for expensive third-generation sequencers or specialized droplet-forming equipment. Based in Canton, Massachusetts, the company is located at 780 Dedham Street Suite 800, Canton, MA 02021, United States, and operates with a small team of 2-10 employees. Recent activities include the March 2023 launch of a high-throughput microbial WGS library preparation kit and a partnership with TATAA Biocenter to offer long-read sequencing application services, reflecting ongoing product development and collaboration; the company reports revenue in the range of $1 million to $10 million.

Get verified Universal Sequencing Technology emails free

Company overview Employee directory